Melanoma, Malignant Recruiting Phase 1 / 2 Trials for Fludarabine (DB01073)

Also known as: Malignant Melanoma / [M]Malignant melanoma NOS / Melanoma / Melanoma malignant

IndicationStatusPhase
DBCOND0107071 (Melanoma, Malignant)Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02111850T Cell Receptor Immunotherapy Targeting MAGE-A3 for Patients With Metastatic Cancer Who Are HLA-DP0401 PositiveTreatment